These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 24310658)

  • 1. IGF1(CA)19 and IGFBP-3-202A/C gene polymorphism and cancer risk: a meta-analysis.
    Quan H; Tang H; Fang L; Bi J; Liu Y; Li H
    Cell Biochem Biophys; 2014 May; 69(1):169-78. PubMed ID: 24310658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3).
    Patel AV; Cheng I; Canzian F; Le Marchand L; Thun MJ; Berg CD; Buring J; Calle EE; Chanock S; Clavel-Chapelon F; Cox DG; Dorronsoro M; Dossus L; Haiman CA; Hankinson SE; Henderson BE; Hoover R; Hunter DJ; Kaaks R; Kolonel LN; Kraft P; Linseisen J; Lund E; Manjer J; McCarty C; Peeters PH; Pike MC; Pollak M; Riboli E; Stram DO; Tjonneland A; Travis RC; Trichopoulos D; Tumino R; Yeager M; Ziegler RG; Feigelson HS;
    PLoS One; 2008 Jul; 3(7):e2578. PubMed ID: 18596909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IGFBP-3 promoter polymorphism -202A>C (rs2854774) contributes to prostate cancer risk: evidence based on 9,482 subjects.
    Ding Q; Shi Y; Fan B; Fan Z; Wang J
    Urol Int; 2014; 93(1):100-7. PubMed ID: 24457161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between IGF1 CA repeat polymorphisms and breast cancer risk: a meta-analysis.
    Huang Q; Wang C; Qiu LJ; Shao F; Yu JH
    Breast Cancer Res Treat; 2011 Aug; 129(1):191-4. PubMed ID: 21390492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians.
    Schumacher FR; Cheng I; Freedman ML; Mucci L; Allen NE; Pollak MN; Hayes RB; Stram DO; Canzian F; Henderson BE; Hunter DJ; Virtamo J; Manjer J; Gaziano JM; Kolonel LN; Tjønneland A; Albanes D; Calle EE; Giovannucci E; Crawford ED; Haiman CA; Kraft P; Willett WC; Thun MJ; Le Marchand L; Kaaks R; Feigelson HS; Bueno-de-Mesquita HB; Palli D; Riboli E; Lund E; Amiano P; Andriole G; Dunning AM; Trichopoulos D; Stampfer MJ; Key TJ; Ma J
    Hum Mol Genet; 2010 Aug; 19(15):3089-101. PubMed ID: 20484221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations among IRS1, IRS2, IGF1, and IGFBP3 genetic polymorphisms and colorectal cancer.
    Slattery ML; Samowitz W; Curtin K; Ma KN; Hoffman M; Caan B; Neuhausen S
    Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1206-14. PubMed ID: 15247132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Grade-specific prostate cancer associations of IGF1 (CA)19 repeats and IGFBP3-202A/C in blacks and whites.
    Hoyo C; Grubber J; Demark-Wahnefried W; Marks JR; Freedland SJ; Jeffreys AS; Grambow SC; Wenham RM; Walther PJ; Schildkraut JM
    J Natl Med Assoc; 2007 Jul; 99(7):718-22. PubMed ID: 17668637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms in the IGF-1 and IGFBP 3 promoter and the risk of breast cancer.
    Wagner K; Hemminki K; Israelsson E; Grzybowska E; Söderberg M; Pamula J; Pekala W; Zientek H; Mielzynska D; Siwinska E; Försti A
    Breast Cancer Res Treat; 2005 Jul; 92(2):133-40. PubMed ID: 15986122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of insulin-like growth factor-1 CA repeat polymorphism on breast cancer risk along with race: a meta-analysis.
    He B; Xu Y; Pan Y; Li R; Gao T; Song G; Gu L; Nie Z; Chen L; Wang S
    Gene; 2013 Aug; 525(1):92-8. PubMed ID: 23628798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IGF1 (CA)19 repeat and IGFBP3 -202 A/C genotypes and the risk of prostate cancer in Black and White men.
    Schildkraut JM; Demark-Wahnefried W; Wenham RM; Grubber J; Jeffreys AS; Grambow SC; Marks JR; Moorman PG; Hoyo C; Ali S; Walther PJ
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):403-8. PubMed ID: 15734965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGF gene polymorphisms and breast cancer in African-American and Hispanic women.
    Sarkissyan M; Mishra DK; Wu Y; Shang X; Sarkissyan S; Vadgama JV
    Int J Oncol; 2011 Jun; 38(6):1663-73. PubMed ID: 21455574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variation in IGF1, IGFBP3, IRS1, IRS2 and risk of breast cancer in women living in Southwestern United States.
    Slattery ML; Sweeney C; Wolff R; Herrick J; Baumgartner K; Giuliano A; Byers T
    Breast Cancer Res Treat; 2007 Aug; 104(2):197-209. PubMed ID: 17051426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IGF1 CA repeat polymorphisms, lifestyle factors and breast cancer risk in the Long Island Breast Cancer Study Project.
    Cleveland RJ; Gammon MD; Edmiston SN; Teitelbaum SL; Britton JA; Terry MB; Eng SM; Neugut AI; Santella RM; Conway K
    Carcinogenesis; 2006 Apr; 27(4):758-65. PubMed ID: 16332723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis of the association of IGFBP3 and IGF1 polymorphisms with susceptibility to colorectal cancer.
    Wang W; Wu BQ; Chen GB; Zhou Y; Li ZH; Zhang JL; Ding YL; Zhang P; Wang JQ
    Neoplasma; 2018 Nov; 65(6):855-864. PubMed ID: 30334445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGF-I and IGFBP-3 polymorphisms and risk of prostate cancer.
    Friedrichsen DM; Hawley S; Shu J; Humphrey M; Sabacan L; Iwasaki L; Etzioni R; Ostrander EA; Stanford JL
    Prostate; 2005 Sep; 65(1):44-51. PubMed ID: 15800934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haplotype-based association studies of IGFBP1 and IGFBP3 with prostate and breast cancer risk: the multiethnic cohort.
    Cheng I; Penney KL; Stram DO; Le Marchand L; Giorgi E; Haiman CA; Kolonel LN; Pike M; Hirschhorn J; Henderson BE; Freedman ML
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1993-7. PubMed ID: 17035411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphisms in IGF-I and IGFBP-3 are associated with prostate cancer in the Chinese population.
    Qian J; Zhou H; Chen J; Ding Q; Cao Q; Qin C; Shao P; Li P; Cai H; Meng X; Ju X; Wang M; Zhang Z; Li J; Hua L; Yin C
    PLoS One; 2014; 9(2):e85609. PubMed ID: 24586243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms in the insulin like growth factor 1 and IGF binding protein 3 genes and risk of colorectal cancer.
    Pechlivanis S; Wagner K; Chang-Claude J; Hoffmeister M; Brenner H; Försti A
    Cancer Detect Prev; 2007; 31(5):408-16. PubMed ID: 18031946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer risk in relation to selected genetic polymorphisms in insulin-like growth factor-I, insulin-like growth factor binding protein-3, and insulin-like growth factor-I receptor.
    Chen C; Freeman R; Voigt LF; Fitzpatrick A; Plymate SR; Weiss NS
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2461-6. PubMed ID: 17164371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IGF-I (CA) repeat polymorphisms and risk of cancer: a meta-analysis.
    Chen X; Guan J; Song Y; Chen P; Zheng H; Tang C; Wu Q
    J Hum Genet; 2008; 53(3):227-238. PubMed ID: 18188667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.